Ilya Kister

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Natural History of Multiple Sclerosis Symptoms

Ilya Kister, Tamar Bacon, Eric Chamot et al. · International Journal of MS Care · 2013 · 452 citations · Full text

Nursing, Neurology, Neuropsychiatry +16

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Anna He, B. Merkel, J William L Brown et al. · The Lancet Neurology · 2020 · 438 citations · Full text

Life Sciences, Neurology, Neuroscience +8

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing

Lana Zhovtis Ryerson, John Foley, Ih Chang et al. · Neurology · 2019 · 194 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Disability in multiple sclerosis

Ilya Kister, Eric Chamot, Amber Salter et al. · Neurology · 2013 · 177 citations · Full text

Medicine, Neurology, Disability Management +16